Clinical Trials Browser

Obesity, Ovarian Neoplasms, Weight Loss, Endometrial Neoplasms

NCT07173829 2025-09-15

BORDEAUX-GLIO

Not yet recruiting

45 enrolled

CNS

Glioblastoma

NCT05463796 2025-08-07

InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer

Recruiting

5,000 enrolled

GastrointestinalGynecologicOther hematologic neoplasmThoracic

Barrett Esophagus, Carcinoma in Situ, Endometrial Hyperplasia, Fibrosis, Giant Cell Tumors, Lung Neoplasms, Osteochondroma, Carcinoma, Lobular, Nevus, Epithelioid and Spindle Cell, Hematologic Neoplasms, Non-alcoholic Fatty Liver Disease

NCT04666090 2025-05-15

Carrelizumab, Chemotherapy and Apatinib in the Neoadjuvant Treatment of Resectable Esophageal Squamous Cell Carcinoma

Phase 2 Active not recruiting

42 enrolled

Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT02809222 2021-04-19

PLASMYC

Phase NA Completed

138 enrolled

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Preleukemia

Clinical Trials

METERMUS-IMC

BORDEAUX-GLIO

InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer

Carrelizumab, Chemotherapy and Apatinib in the Neoadjuvant Treatment of Resectable Esophageal Squamous Cell Carcinoma

PLASMYC